KAERUS BIOSCIENCE LIMITEDActive
Key figures
Like most small UK companies, KAERUS BIOSCIENCE LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025Balance sheet structure
Filed accounts2019/20–2025
| 2019/20 | 2020/21 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 331,163 | 81,369 | 2,483,729 | 2,055,366 | 864,303 |
| Total assets | 473,454 | 104,028 | 2,674,547 | 2,148,959 | 9,945,671 |
| Total liabilities | 347,609 | 934,414 | 597,899 | 316,972 | 295,392 |
| Net assets / total equity | 165,400 | -790,831 | 2,076,650 | 1,831,989 | 9,650,281 |
| Average number of employees | 4 | 4 | 0 | 6 | 4 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: KAERUS BIOSCIENCE LIMITED
Company
KAERUS BIOSCIENCE LIMITED is a private limited company registered with Companies House under company number 10274924. It was incorporated on 12 Jul 2016. Its status is active. The registered office is in London (E1). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £9,650,281, up 426.8% on the previous year. Cash at bank and in hand was £864,303. Total assets were £9,945,671 and total liabilities £295,392. The company had an average of 4 employees. Figures are available for 5 financial years (2019/20–2025).
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 25 Jul 2027.